JPMorgan Starts Luminex (LMNX) at Neutral

July 18, 2008 8:08 AM EDT

JPMorgan initiates coverage on Luminex Corporation (Nasdaq: LMNX) with a Neutral rating.

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for applications in the life sciences industry.


Related Categories

New Coverage

Stocks Mentioned

LMNX 17.73

+0.00 +0.00%
Volume: 219,349
Track LMNX


Related Entities


Add Your Comment